TY - JOUR T1 - Myositis as a manifestation of SARS-CoV-2 JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis SP - e42 LP - e42 DO - 10.1136/annrheumdis-2020-217573 VL - 80 IS - 3 AU - Maxime Beydon AU - Kevin Chevalier AU - Omar Al Tabaa AU - Sabrina Hamroun AU - Anne-Sophie Delettre AU - Marion Thomas AU - Julia Herrou AU - Elodie Riviere AU - Xavier Mariette Y1 - 2021/03/01 UR - http://ard.bmj.com/content/80/3/e42.abstract N2 - We read with great interest the paper from Monti et al describing clinical course of coronavirus disease 2019 (covid-19) in patients with chronic arthritis. We would like to emphasise that symptoms mimicking connective tissue disease can occur at the early phase of covid-19 infection.1 Despite the fact that myalgia has been already reported in several cohorts of patients with covid-19 infection,2 myositis was not described in these studies. We report a case of a MRI-documented myositis secondary to covid-19 in a patient. The patient was not under medication prior to the illness. Symptoms appeared suddenly on waking with diffuse myalgias and proximal lower limb muscle weakness, causing him to fall. On arrival at the hospital, the patient was afebrile and did not present any upper or lower airway symptoms. Motor testing revealed a bilateral hip flexion deficit graded at 3/5 on the Medical Research … ER -